Robyn J. Barst, MD
Columbia University and Cornell Medical Center
New York, New York
Presentation Title
Current Therapy of Pulmonary Arterial Hypertension: Prostanoids,
Endothelin Receptor Antagonists and Phosphodiesterase Inhibitors (Summary of Presentation)
Dr. Barst is Professor of Pediatrics in the Divisions of Pediatric Cardiology at Columbia University College of Physicians & Surgeons and Cornell Medical Center in New York, and Director of New York Presbyterian Pulmonary Hypertension Center at Columbia University Medical Center. She received her medical degree from the University of North Carolina, Chapel Hill, and completed an internship and residency in pediatrics as well as fellowships in pediatric cardiology and pediatric pulmonary medicine at Columbia University College of Physicians & Surgeons in New York.
Dr. Barst has focused much of her research on the pathogenesis and treatment of pulmonary arterial hypertension. Currently, she is an investigator for studies on the genetic aspects of pulmonary arterial hypertension and the use of novel therapeutic modalities to treat pulmonary arterial hypertension including prostacyclin analogues, endothelin receptor antagonists, and phosphodiesterase inhibitors. She is also a frequent presenter at various symposia on pulmonary vascular disorders. In addition, she is an active contributor to the medical and scientific press and has published numerous articles in Circulation, the New England Journal of Medicine, Chest, and similar publications.
Dr. Barst is a Fellow of the American Academy of Pediatrics Section on Cardiology and Cardiac Surgery; of the American Heart Association Council on Cardiovascular Disease in the Young and Council on Cardiopulmonary, Perioperative and Critical Care; of the American College of Chest Physician; and of the American College of Cardiology. She is immediate past Chairman of the American Heart Association (AHA) Council on Cardiovascular Disease in the Young. In addition, she is a member of the European Society of Cardiology Task Force for Primary Pulmonary Hypertension and a consultant to the National Heart, Lung and Blood Institute (NHLBI) Division of Lung Diseases and Office of Rare Diseases. Among her editorial responsibilities, Dr. Barst is a board member of Circulation and an abstract reviewer for Annual Scientific Sessions of the AHA and American Thoracic Society. Professional accolades include the Scleroderma Foundation Research, Education, and Support Award; the Clinician-Scientist Award, AHA; and the Clinical Investigator Award, NHLBI.